Heather M. Snyder, Ph.D. Director, Medical & Scientific Relations

Similar documents
National Plan to Address Alzheimer s Disease

FY12 FY14 Strategic Plan

Non-Pharmacological Strategies to Ameliorate Symptoms of Alzheimer s Disease and Related Dementia (NPSASA)

2017 CURE - Sleep and Epilepsy Award Request for Applications (RFA) with LOI & Full Proposal Guidelines

Patient-Centered Cancer Treatment Planning: Improving the Quality of Oncology Care

Paint the Night Purple

Saving Lives, Improving Health: Redesigning Opioid Use Disorder Care

NIH FY 2017 Budget Roll-Out Francis S. Collins, M.D., Ph.D. Director, National Institutes of Health February 9, 2016

Parkinson s Research Program

Research Funding Opportunities at the National Institutes of Health

Chief Development Officer National Brain Tumor Society

THE MICHAEL J. FOX FOUNDATION FOR PARKINSON S RESEARCH. Funding Opportunities

Defense Health Program Department of Defense Lung Cancer Research Program. Funding Opportunities for Fiscal Year 2017 (FY17)

A Unique Partnership to Advance Alzheimer's Research through Whole Genome Sequencing.

Paediatric and Adolescent HIV Research Grant Programme

The Congressionally Directed Medical Research Programs Funding Opportunities: Peer Reviewed Cancer Research Program

FROM THE ALZHEIMER S ASSOCIATION INTERNATIONAL CONFERENCE 2018

Request for Applications Basic, Clinical and Population Science Pilot Awards

Type 1 Diabetes Australian Research Impact Analysis

Melanoma Research Alliance-Pfizer Academic-Industry Partnership Awards

NEW NATIONAL STRATEGY FOR RECRUITMENT AND PARTICIPATION IN ALZHEIMER S DISEASE CLINICAL TRIALS TAKES SHAPE

2017 ALZHEIMER'S DISEASE FACTS AND FIGURES

Homelessness is a complex issue but it is not an unsolvable problem. It can be ended and philanthropy has a vital role to play.

UC Brain Tumor Center Molecular Therapeutics Pilot Grant Program 2013/2014

Marc Moss, MD President, American Thoracic Society (202) th St, N.W. #300 Washington, DC 20036

LCFA/IASLC LORI MONROE SCHOLARSHIP IN TRANSLATIONAL LUNG CANCER RESEARCH 2017 REQUEST FOR APPLICATION (RFA)

Washtenaw Coordinated Funding. Investment Summary

Momentum Awards: Institutional pumppriming awards for dementia research

Alzheimer s Disease and Related Disorders: The Public Health Call to Action

Principal actions to date:

FY STRATEGIC PLAN. FY2016 Q1 Goal and Strategy Progress Report

1 November, 2013 or earlier

VA Funding Opportunities & Research Resources

STRATEGIC PLAN

Introduction to the Patient- Centered Outcomes Research Institute

Translating Duke Health. Accelerating discovery and its translation

New Initiatives in Nutrition Research at NIH. Paul M. Coates, Ph.D. DC IFT Food Policy Impact 2018

1. Goal: Enhance the resident s clinical skills in pediatric optometry, vision therapy, and neurooptometric

2012 Annual Report. The Legacy of Angels Foundation is a private family 501 (c) (3) organization co-founded by Paul and Sue Rosenau in 2008.

Strategic Plan Executive Summary Society for Research on Nicotine and Tobacco

Epilepsy Foundation North/ Central Illinois. FY19-FY21 3 year Strategic Plan 20 June 2018

ESRC-NIHR dementia research initiative 2018 outline call Call specification

CEO Operational Report. Annual General Meeting 23 October 2013

The Coalition s Policy to Boost Dementia Research

Treatment of Multiple Sclerosis

NIH Initiatives in Nutrition: Roadmap, Strategic Plan

Department of Defense Duchenne Muscular Dystrophy Research Program (DMDRP)

Evaluations. Dementia Update: A New National Plan for Alzheimer s Disease Research, Care and Services. Disclosure Statements.

AGS Sleep Meeting. Marie A. Bernard, M.D. Deputy Director National Institute on Aging. October 4, 2015

Peace Corps Global HIV/AIDS Strategy (FY )

PCORI s Role in Supporting CER

STTR TRANSFORMATIVE TEAM GRANTS APPLICATION

National Cancer Institute Clinical Trial Cooperative Groups

ESMO FELLOWSHIP PROGRAMME & LEADERS GENERATION PROGRAMME

Program Priorities 2018

I, Mary M. Langman, Director, Information Issues and Policy, Medical Library Association

National Alzheimer s project U.S.

Tuberous Sclerosis Complex Research Program

Re: Request for Information: Updating the Alzheimer s Disease-Related Dementias Research Priorities

SPONSORSHIP OPPORTUNITIES

Consultation on Australian Medical Research and Innovation Priorities for

ALZHEIMER S ASSOCIATION

SUPPORT FEDERAL FUNDING FOR PARKINSON S DISEASE RESEARCH AND DRUG DEVELOPMENT

The Academy Capitol Forum: Meet the Experts. Diagnosing Which Health Treatments Improve Outcomes: A PCORI Overview and How to Get Involved

Partnering with the American Cancer Society $62.7 MILLION

TRDRP Tobacco Policy Research Centers 2018 Call for Applications. Applicant Informational Webinar

NCI s Office of of Centers, Training & Resources: Fostering Progress in in Cancer Health Disparities Research

Opportunities for Statistical Modeling and Computation at the National Institute of Mental Health (NIMH), NIH

About the Modern Language Association

introduction TEAM CAPTAIN COMPANY GUIDE

SPONSORSHIP OPPORTUNITIES

Research For the Future. Len Lichtenfeld, MD, MACP Interim Chief Medical and Scientific Officer

Research commission: GUIDANCE FOR APPLICANTS

REPORT. A Model Clinical Trials System for the 21st Century

Peer Reviewed Alzheimer s Research Program

5th International Conference on. Spine and Spinal Disorders. April 25-26, 2019


Fast-Forwarding a Cure for Melanoma

The Prime Minister s Challenge on Dementia & 2013, G8 Dementia Legacy Making it Happen

Treatments of tomorrow: dementia research and drug discovery. Dr Matthew Norton Director of Policy and Strategy, Alzheimer s Research UK

Testimony of Robert Egge, Vice President of Public Policy Alzheimer s Association. December 8, 2010

IMPACT APA STRATEGIC PLAN

Catalyzing the Next Generation of Cancer Technologies

HIV and Drug Use Research Fellowship. Programme and Application Webinar

Integrating Geriatrics into the Specialties of Internal Medicine. Workshop on Wound Repair and Healing in Older Adults February 20-21, 2014

LEADERSHIP PROFILE. CURE Childhood Cancer believes that childhood cancer can be cured in our lifetime. -- CURE Childhood Cancer s Vision

2019 Board of Directors Elections Candidate Statement SANDY RENNIE

Request for Applications Post-Traumatic Stress Disorder GWAS

Strategic Plan: Implementation Work Plan

American Cancer Society Research Programs

INTERNATIONAL RESEARCH GRANT PROGRAM ANNOUNCEMENT New Investigators Program. (July 2013 January 2014)

Sponsorship Opportunities

Global Action Against Dementia: Finding a Path Forward and the World Dementia Council

A Blueprint for Breast Cancer Deadline 2020

Investor Update. Downloads. Services PDF. Basel, 17 July 2017

Leadership Networking: Finding Your Community (I)

Autism Speaks Local Impact Grants. Presented by Serena Selkin, Director, Grants.

Overview of the NIH. National Institutes of Health (NIH)

Claims & Underwriting. You already told us that story! Maria C. Carrillo, Ph.D. Sr. Director, Medical & Scientific Relations Alzheimer s Association

Transcription:

Heather M. Snyder, Ph.D. Director, Medical & Scientific Relations 1

Overview Landscape of Alzheimer s disease National Plan to Address Alzheimer s disease More information about the Alzheimer s Association Alzheimer s Association Science Initiatives and International Research Grant Program 2

Alzheimer s and Mortality 6 th leading cause of death across all ages 5 th leading cause of death for those aged 65 and older Only cause of death among the top 10 in America without a way to prevent, cure or even slow its progression. Breast Cancer -2% Prostate Cancer -8% Change in the Number of Deaths: 68% Between 2000 and 2010 Heart Disease -16% Stroke -23% HIV -42% Alzheimer's Disease 68% Based on preliminary 2010 3

National Alzheimer s Plan Contains goal to Prevent and Effectively Treat Alzheimer s by 2025 Key strategies: Increase trial recruitment Expand scale and scope of research Accelerate drug development 4

Global Research & Development Funding Trends 5

Alzheimer s is Underfunded % Change in Deaths (2000-2010) Research Funding Est. FY13 (in Billions) 6

Our vision is a world without Alzheimer s disease Our mission: Advance research Provide care and support Increase Concern & Awareness Public Policy & Advocacy Efforts 7

Alzheimer s Association is a global leader in Alzheimer s research Amyloid Imaging Taskforce (AIT) 8

Convening & Connecting Scientists Around the Globe 9

Alzheimer s Association International Society to Advance Alzheimer's Research and Treatment Professional society of the Alzheimer s Association, representing scientists and clinicians Mission: To increase the rate of progress of Alzheimer s and dementia research Currently, there are approximately 2,000 ISTAART members 10

Alzheimer s Association International Society to Advance Alzheimer's Research and Treatment Professional Interest Areas (PIAs) PIAs are affinity groups within ISTAART that allow Alzheimer s researchers with interests in specific subspecialties to network and collaborate Number of PIAs 11

Articles from our journal are downloaded an average of 30,000 times per month Impact Factor 6.4 14.5 12

13

Largest Private Funder of Alzheimer's Research in the World Over $315 million to more than 2,200 scientific investigations since 1982 Currently, over 350 on-going research projects in 21 countries funded by the Alzheimer s Association Community of 5,500 active peer-review volunteer scientists from over 60 countries Fund broad spectrum of research (socialbehavioral, cognitive, functional, basic, clinical) through open or targeted grant programs to scientists at all stages of their career 14

Peer Review Process ** LOI REVIEW ** 1 st Tier Review: peer review of 3-4 reviewers per application Threaded discussion Inflammatory evaluation 2 nd Tier Review: MSAC Evaluation and Adjudication Divergent adjudication Zenith 3 rd Tier Review 15

LOI Review &Application Process Alignment with the research priorities of the Alzheimer s Association Demonstrable innovation/novelty of the proposed project (especially in the context of the PIs recently funded work) Impact of project on Alzheimer s disease and related dementia research Established investigators from other fields new to Alzheimer s and related dementia research Evidence of methodological rigor that address the research question(s) being proposed 16

All Investigators Program PROGRAM SUMMARY KEY DATES Program Announcement By November 30, 2013 Letter of Intent: Open Date January 2014 Deadline Date February 2014 Application Deadline- April 2014 Review Process May June, 2014 Award Announcement - By August 30, 2014 Alz.org/researchers 17

All Investigator Program Grant Opportunities New Investigator Research Grant (NIRG) Max. Per Year $60,000; Max. $100,000/2 years New Investigator Research Grant to Promote Diversity (NIRGD) Per Year $60,000; Maximum $100,000/2 years Mentored New Investigator Research Grant to Promote Diversity (MNIRGD) Per Year $60,000; Maximum $150,000/3 years 18

All Investigator Program Grant Opportunities Zenith Fellows Award Max. Per Year $250,000; Max. $450,000/3 years Everyday Technologies for Alzheimer Care Max. Per Year $90,000; Max. $200,000/3 years Investigator Initiated Research Grant (IIRG) in Targeted Research Areas Max. Per Year $100,000; Max. $240,000/ 3 years 19

All Investigator Program Grant Opportunities Offer targeted requests for applications (RFA) - not confirmed for 2014 In 2013, offered: Understanding the Development and Devising Treatments for Alzheimer s Disease in Individuals with Down Syndrome (DS/AD) Early Career Award Investigator Initiated 20

NEW INVESTIGATORS PROGRAM: FALL 2013 21

New Investigators PROGRAM SUMMARY KEY DATES Letter of Intent: Open Date August 2014 Deadline Date September 2014 Application Deadline October 2014 Review Process November - December 2014 Award Announcement By January 30, 2015 Alz.org/grants 22

SCIENCE INITIATIVES/ ACTIVITIES OF THE ALZHEIMER S ASSOCIATION 23

Lead Funder of the DIAN-TU $4.2M grant to DIAN-TU International studies in the US, UK, Japan, and Australia Expansion of DIAN database Three simultaneous trials to test potential therapies: Gantenerumab (Roche, Monoclonal antibody to AB) Solaneuzumab (Lilly, Monoclonal antibody to AB) TBD Figures courtesy of Randall Bateman, MD, DIAN-TU 24

Global Alzheimer s Association Interactive Network (GAAIN) Open Access Growing trend in science Provides an incredible return on investment for funded research Unprecedented database Provide researchers worldwide with free-ofcharge access to a vast repository of data Sophisticated analytical tools; massive computational power to ask complex questions 25

In Summary Alzheimer s disease global health crisis Association leads a number of efforts to support the community, AAIC, TrialMatch, ISTAART and Alzheimer s & Dementia Inside look at the International Research Grant Program programs, dates and tips - All Investigators Program Spring 2014 - New Investigators Program Fall 2014 Other resources 26

Thank you for your time! www.alz.org/research 27

28 alz.org